IDEAYA Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $55.5M | $55.0M | $493.0K | $3.6M |
| FY2021 | $-55.8M | $-58.4M | $2.6M | $8.2M |
| FY2022 | $-87.2M | $-90.6M | $3.4M | $11.6M |
| FY2023 | $-115.2M | $-117.6M | $2.4M | $18.5M |
| FY2024 | $-247.6M | $-251.4M | $3.9M | $34.7M |